Similar articles

• [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].

  Szczepanski A. Szczepanski A. Przegl Dermatol. 1971 May-Jun;58(3):355-9. Przegl Dermatol. 1971. PMID: 4944035 Review. Polish. No abstract available.
• [Effects and adverse effects of D-penicillamine].

  Perings E, Junge U. Perings E, et al. Med Klin. 1975 Aug 1;70(31):1265-74. Med Klin. 1975. PMID: 1107780 Review. German. No abstract available.
• Vesicular lesions in a woman with progressive systemic sclerosis. Penicillamine-induced intradermal vesicles: an example of human lathyrism.

  Godar JM, Norins AL. Godar JM, et al. Arch Dermatol. 1992 Jul;128(7):977-8, 980-1. doi: 10.1001/archderm.128.7.977b. Arch Dermatol. 1992. PMID: 1626968 No abstract available.
• Chemical basis for pharmacological and therapeutic actions of penicillamine.

  Friedman M. Friedman M. Proc R Soc Med. 1977;70 Suppl 3(Suppl 3):50-60. doi: 10.1177/00359157770700S320. Proc R Soc Med. 1977. PMID: 122675 Free PMC article. Review. No abstract available.
• [Treatment of chronic hepatitis and primary biliary liver cirrhosis with D-penicillamine].

  Mansurov KhKh, Mirodzhov GK, Ladnaia MM. Mansurov KhKh, et al. Klin Med (Mosk). 1981 Feb;59(2):91-5. Klin Med (Mosk). 1981. PMID: 7289493 Russian. No abstract available.